Nouvelle déclaration d'incident
No de la demande: 2021-1854
Numéro de référence du titulaire d'homologation: 2021-US-003022
Nom du titulaire (nom légal complet, aucune abbréviation): The Hartz Mountain Corporation
Adresse: 400 Plaza Drive
Ville: Secaucus
État: New Jersey
Pays: USA
Code postal /Zip: 07094-3688
Incident chez un animal domestique
Pays: UNITED STATES
État: NEW YORK
Inconnu
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 2596-153
Nom du produit: Hartz UltraGuard Rid Flea and Tick Shampoo for Dogs 18oz
Liquide
Oui
Inconnu
Site: Animal / Usage sur un animal domestique
Inconnu
Propriétaire de l'animal
Dog / Chien
Neapolitan Mastiff
1
Homme
2
80
lbs
Cutanée
Unknown / Inconnu
Unknown / Inconnu
Système
Persisted until death
Inconnu
Inconnu
Mort
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
On an unknown date in 2020, a 2 year old, 80 pound, male, Neapolitan Mastiff dog of unknown reproductive status, in unknown condition, with no known concomitant medical condition, was administered a unknown amount of Hartz UltraGuard Rid Flea and Tick Shampoo for Dogs 18oz (Phenothrin (Sumithrin)) via the topical route by the animal owner. The product was administered to the dog from two separate bottles with different lot numbers. On an unknown date post product administration, the dog died. No further information was provided or received.
Mort
Assessment: This product contains a pyrethroid insecticide at low concentration and therefore has a wide margin of safety in dogs when used per label directions. Even if ingested, only minor GI upset would be expected. Very minimal information was provided in this case including the timeline of product use in relation to death. Without more information, this case cannot be evaluated further. The information contained in this report is based on self-reported statements provided to the registrant during telephone interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.